Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,923 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta-analysis of real-world survival outcomes of East Asian patients with advanced non-small cell lung cancer treated with first-line EGFR-TKIs.
Chang HC, Wang CC, Tseng CC, Huang KT, Chen YM, Chang YP, Lai CH, Fang WF, Lin MC, Chuang HY. Chang HC, et al. Among authors: lai ch. Thorac Cancer. 2023 Nov;14(32):3208-3216. doi: 10.1111/1759-7714.15111. Epub 2023 Sep 22. Thorac Cancer. 2023. PMID: 37737541 Free PMC article.
Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
Chang HC, Chen YM, Tseng CC, Huang KT, Wang CC, Chen YC, Lai CH, Fang WF, Kao HC, Lin MC. Chang HC, et al. Among authors: lai ch. Tumour Biol. 2017 Mar;39(3):1010428317695939. doi: 10.1177/1010428317695939. Tumour Biol. 2017. PMID: 28351317 Free article.
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM, Lai CH, Chang HC, Chao TY, Tseng CC, Fang WF, Wang CC, Chung YH, Wang YH, Su MC, Huang KT, Chen HC, Chang YC, Lin MC. Chen YM, et al. Among authors: lai ch. PLoS One. 2015 Aug 27;10(8):e0136252. doi: 10.1371/journal.pone.0136252. eCollection 2015. PLoS One. 2015. PMID: 26313661 Free PMC article.
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM, Lai CH, Chang HC, Chao TY, Tseng CC, Fang WF, Wang CC, Chung YH, Wang YH, Su MC, Liu SF, Huang KT, Chen HC, Chang YC, Lin MC. Chen YM, et al. Among authors: lai ch. PLoS One. 2016 Feb 19;11(2):e0149722. doi: 10.1371/journal.pone.0149722. eCollection 2016. PLoS One. 2016. PMID: 26894507 Free PMC article.
1,923 results